Stockreport

Enlivex Therapeutics Completes Recruitment In Phase Ib Trial Evaluating Safety And Efficacy Of Universal Off-The-Shelf Allocetra In Patients With Severe Sepsis

Enlivex Therapeutics Ltd. - Ordinary Shares  (ENLV) 
PDF Nes Ziona, Israel, Nov. 18, 2019 (GLOBE NEWSWIRE) --   Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today reported completion of p [Read more]